Mannatech (MTEX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $7.13, -1.66% vs the prior close of $7.25.
- Volume 20.30K shares, 0.6x its 50-day average.
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
MTEX dips 1.7% to $7.13, 5 down days in a row. Closed at $7.13, -1.66% vs the prior close of $7.25. Day range $6.92–$7.55, opened at $7.37.
MTEX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MTEX dips 1.7% to $7.13, 5 down days in a row
- Closed at $7.13, -1.66% vs the prior close of $7.25. Day range $6.92–$7.55, opened at $7.37.
- Volume was 20.30K shares, 0.6x its 50-day average of 31.77K.
- Price is +0.4% vs its 50-day average ($7.10) and +13.9% vs its 200-day average ($6.26).
- 52-week range $3.80–$12.45; today's close sits at 38% of that range, 42.7% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — MTEX slides 4.1% to $7.25, 4 down days in a row
- Closed at $7.25, -4.10% vs the prior close of $7.56. Day range $7.19–$7.38, opened at $7.23.
- Volume was 4.60K shares, 0.1x its 50-day average of 31.81K — lighter than usual.
- Price is +2.6% vs its 50-day average ($7.06) and +15.7% vs its 200-day average ($6.27).
- 52-week range $3.80–$12.45; today's close sits at 40% of that range, 41.8% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — MTEX dips 3.0% to $7.56, 3 down days in a row
- Closed at $7.56, -2.95% vs the prior close of $7.79. Day range $7.46–$8.20, opened at $7.80.
- Volume was 28.00K shares, 0.9x its 50-day average of 31.81K.
- Price is +7.7% vs its 50-day average ($7.02) and +20.6% vs its 200-day average ($6.27).
- 52-week range $3.80–$12.45; today's close sits at 43% of that range, 39.3% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — MTEX dips 0.9% to $7.79
- Closed at $7.79, -0.89% vs the prior close of $7.86. Day range $7.35–$8.07, opened at $7.35.
- Volume was 32.90K shares, 1.0x its 50-day average of 31.38K.
- Price is +11.8% vs its 50-day average ($6.97) and +24.2% vs its 200-day average ($6.27).
- 52-week range $3.80–$12.45; today's close sits at 46% of that range, 37.4% below the 52-week high.
Oct 9, 2026 — MTEX ends flat (+0.0%) to $7.86 on 2.0x normal volume
- Closed at $7.86, +0.00% vs the prior close of $7.86. Day range $7.50–$7.96, opened at $7.60.
- Volume was 59.60K shares, 2.0x its 50-day average of 30.45K — unusually heavy trading.
- Price is +13.8% vs its 50-day average ($6.91) and +25.3% vs its 200-day average ($6.27).
- 52-week range $3.80–$12.45; today's close sits at 47% of that range, 36.9% below the 52-week high.
Oct 8, 2026 — MTEX jumps 4.5% to $7.86
- Closed at $7.86, +4.52% vs the prior close of $7.52. Day range $7.45–$8.11, opened at $7.50.
- Volume was 32.20K shares, 1.1x its 50-day average of 29.89K.
- Price is +14.8% vs its 50-day average ($6.85) and +25.2% vs its 200-day average ($6.28).
- 52-week range $3.80–$12.45; today's close sits at 47% of that range, 36.9% below the 52-week high.
Oct 7, 2026 — MTEX slides 3.5% to $7.52
- Closed at $7.52, -3.47% vs the prior close of $7.79. Day range $7.50–$7.84, opened at $7.73.
- Volume was 8.50K shares, 0.3x its 50-day average of 29.87K — lighter than usual.
- Price is +10.8% vs its 50-day average ($6.79) and +19.8% vs its 200-day average ($6.28).
- 52-week range $3.80–$12.45; today's close sits at 43% of that range, 39.6% below the 52-week high.
Oct 6, 2026 — MTEX jumps 4.8% to $7.79
- Closed at $7.79, +4.85% vs the prior close of $7.43. Day range $7.34–$7.79, opened at $7.37.
- Volume was 41.30K shares, 1.4x its 50-day average of 29.32K.
- Price is +15.8% vs its 50-day average ($6.73) and +24.0% vs its 200-day average ($6.28).
- 52-week range $3.80–$12.45; today's close sits at 46% of that range, 37.4% below the 52-week high.
Oct 5, 2026 — MTEX jumps 11.9% to $7.43
- Closed at $7.43, +11.90% vs the prior close of $6.64. Day range $6.82–$7.69, opened at $6.91.
- Volume was 13.40K shares, 0.5x its 50-day average of 29.33K — lighter than usual.
- Price is +11.3% vs its 50-day average ($6.67) and +18.2% vs its 200-day average ($6.28).
- 52-week range $3.80–$12.45; today's close sits at 42% of that range, 40.3% below the 52-week high.
Oct 2, 2026 — MTEX slides 5.0% to $6.64, a 1-month low, 4 down days in a row
- Closed at $6.64, -5.01% vs the prior close of $6.99. Day range $6.29–$7.00, opened at $6.29.
- Volume was 15.20K shares, 0.5x its 50-day average of 29.28K — lighter than usual.
- Price is +0.4% vs its 50-day average ($6.62) and +5.6% vs its 200-day average ($6.29).
- 52-week range $3.80–$12.45; today's close sits at 33% of that range, 46.7% below the 52-week high.
- That makes 4 straight losses.
MTEX latest news & SEC filings
Every SEC filing by or about MTEX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 19, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 19, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $26.65M (prior year $25.68M) (+3.8% vs Jun 30, 2025)
- Net income: $1.01M (prior year -$4.31M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.53 (prior year -$2.27) (swung to profit vs Jun 30, 2025)
Jun 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 18, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade MTEX
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Apr 15, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.94% (largest 11.9%). That is a volatile stock.
- Liquidity: about 23.82K shares (≈$169.87K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.13 vs a range of $3.80–$12.45 (38% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 0 sales; latest: Larry A Jobe bought 2,803 shares on May 20, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 1, 2026; 8-K Aug 12, 2026.
- Share count: 1.93M shares outstanding (Aug 5, 2026), +1.5% vs a year earlier.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
MTEX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 7.37 | 7.55 | 6.92 | 7.13 | 20.30K |
| Oct 14, 2026 | 7.23 | 7.38 | 7.19 | 7.25 | 4.60K |
| Oct 13, 2026 | 7.80 | 8.20 | 7.46 | 7.56 | 28.00K |
| Oct 12, 2026 | 7.35 | 8.07 | 7.35 | 7.79 | 32.90K |
| Oct 9, 2026 | 7.60 | 7.96 | 7.50 | 7.86 | 59.60K |
| Oct 8, 2026 | 7.50 | 8.11 | 7.45 | 7.86 | 32.20K |
| Oct 7, 2026 | 7.73 | 7.84 | 7.50 | 7.52 | 8.50K |
| Oct 6, 2026 | 7.37 | 7.79 | 7.34 | 7.79 | 41.30K |
| Oct 5, 2026 | 6.91 | 7.69 | 6.82 | 7.43 | 13.40K |
| Oct 2, 2026 | 6.29 | 7.00 | 6.29 | 6.64 | 15.20K |
| Oct 1, 2026 | 7.42 | 7.42 | 6.74 | 6.99 | 10.20K |
| Sep 30, 2026 | 7.70 | 7.74 | 7.15 | 7.18 | 25.70K |
| Sep 29, 2026 | 7.73 | 7.93 | 7.55 | 7.60 | 7.00K |
| Sep 28, 2026 | 8.19 | 8.19 | 7.62 | 7.83 | 49.10K |
| Sep 25, 2026 | 7.36 | 7.94 | 7.18 | 7.70 | 64.20K |
| Sep 24, 2026 | 6.89 | 7.36 | 6.67 | 7.25 | 4.00K |
| Sep 23, 2026 | 8.25 | 8.25 | 7.66 | 7.66 | 7.60K |
| Sep 22, 2026 | 8.15 | 8.15 | 7.83 | 8.00 | 4.30K |
| Sep 21, 2026 | 7.57 | 8.15 | 7.42 | 8.15 | 22.30K |
| Sep 18, 2026 | 7.76 | 7.78 | 6.11 | 7.51 | 26.10K |
About Mannatech
Mannatech (MTEX) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in FLOWER MOUND, TX. State of incorporation: TX. Fiscal year ends December 31. SEC CIK 1056358.
MTEX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| J Stanley Fredrick | Director | Jan 6, 2026 |
| Larry A Jobe | Director | May 21, 2026 |
| Seifrick A John | Director | Jun 5, 2026 |
| Tyler Rameson | Director | Jan 6, 2026 |
| Kevin Andrew Robbins | Director | May 20, 2026 |
| Robert Toth | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yasir Haider | Chief Financial Officer | Jun 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 20, 2026 | Larry A Jobe | Buy | 2,803 | $4.12 |
| May 19, 2026 | Larry A Jobe | Buy | 5,000 | $4.20 |
| May 19, 2026 | Kevin Andrew Robbins | Buy | 7,100 | $4.17 |
MTEX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $108.04M | $-15.21M | -8.00 | $-2.96M |
| Dec 31, 2024 | $117.87M | $2.49M | 1.32 | $2.26M |
| Dec 31, 2023 | $131.96M | $-2.24M | -1.20 | $-2.37M |
| Dec 31, 2022 | $137.21M | $-4.49M | -2.35 | $-2.60M |
| Dec 31, 2021 | $159.76M | $9.84M | 4.71 | $10.77M |
Latest balance sheet: total assets $27.47M, total liabilities $32.44M, cash $6.03M (as of Jun 30, 2026).
MTEX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $5.07 |
| May 14, 2026 | 8-K Item 2.02 (results) | $4.62 |
| Apr 15, 2026 | 8-K Item 2.02 (results) | $4.96 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $9.51 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $7.50 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| May 12, 2023 | 8-K Item 2.02 (results) | — |
| Mar 17, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Regencell Bioscience (RGC)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)Aurora Cannabis (ACB)Glass House Brands (GLAS)Usana Health Sciences (USNA)Cronos (CRON)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MTEX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.